http://archive.fast-edgar.com/20240603/AW2ZL62CZ22Y9ZZ2222C2ZYMR3O2ZZ223Q62
Filed on: June 3, 2024
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant x
Filed by a Party other than the Registrant ¨
Check the appropriate box:
¨ Preliminary Proxy Statement
¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨ ... (continue reading...)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a16 OR 15d16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2024
Commission File Number: 001-33178
MELCO RESORTS & ENTERTAINMENT LIMITED
71 Robinson Road
#04-03
Singapore (068895)
and
38th Floor, The Centrium
60 Wyndham Street
Central
Hong Kong
(Address of principal executive offices)
... (continue reading...)Filed pursuant to Rule 253(g)(2)
File No. 024-11598
SUPPLEMENT NO. 3 DATED JUNE 1, 2024
TO OFFERING CIRCULAR DATED SEPTEMBER 26, 2023
EMERGING FUELS TECHNOLOGY, INC.
6024 S. 116th East Avenue
Tulsa, Oklahoma 74146
Tel.: 918.286.6802
EXPLANATORY NOTE
This Supplement No. 3 to the Offering Circular should be read in conjunction with the Offering Circular of Emerging Fuels Technology, Inc. (the “company”) dated September 26, 2023 as... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B5 Life360, Inc.
-
Form 6-K TAKEDA PHARMACEUTICAL For: Jun 03
-
Form SCHEDULE 13D/A Avinger Inc Filed by: Zylox-Tonbridge Medical Technology Co., Ltd.
-
Form D A.P. Gilfoyle Laminar
-
Form 6-K RYANAIR HOLDINGS PLC For: Jun 03
-
Form D A.P. Gilfoyle Muon Fund
-
Form 6-K PURPLE BIOTECH LTD. For: Jun 03
-
Form 8-K Greenwave Technology For: May 29
-
Form 6-K INDIVIOR PLC For: Jun 03
-
Form ARS Safe & Green Development For: Dec 31
-
Form 8-K Summit Therapeutics Inc. For: Jun 03
-
Form 6-K Gogoro Inc. For: Jun 03
-
Form N-23C3A Franklin BSP Private For: Jun 03
-
Form SD/A AngloGold Ashanti PLC
-
Form 144 CHECK POINT SOFTWARE Filed by: Spokoiny Alex
-
Form 6-K TOYOTA MOTOR CORP/ For: Jun 03
-
Form 8-K Greenwave Technology For: May 29
-
Form 3 Greenpro Capital Corp. For: Jun 01 Filed by: Chee Wah Chew
-
Form 8-K Greenpro Capital Corp. For: May 31
-
Form 6-K WOODSIDE ENERGY GROUP For: Jun 03
-
Form 6-K HUTCHMED (China) Ltd For: Jun 03
-
Form D/A CW Natural Resources
-
Form 6-K GSK plc For: Jun 03
-
Form 8-K Chemours Co For: May 31
-
Form 6-K Tencent Music Entertainm For: Jun 03
-
Form S-1/A Rapport Therapeutics,
-
Form 6-K INDIVIOR PLC For: Jun 03
-
Form 6-K Burning Rock Biotech For: Jun 03
-
Form 6-K KE Holdings Inc. For: Jun 03
-
Form 6-K SUMITOMO MITSUI FINANCIA For: Jun 03
-
Form 6-K The9 LTD For: Jun 03
-
Form F-1/A Novelis Inc.
-
Form 8-K/A Sharps Technology Inc. For: May 30
-
Form 425 Summit Midstream Partner Filed by: Summit Midstream Partners, LP
-
Form 6-K DR REDDYS LABORATORIES For: Jun 02
-
Form 15-12G Landos Biopharma, Inc.
-
Form F-1/A Mercurity Fintech Holdin
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form EFFECT Context Therapeutics
-
Form 497 Innovator ETFs Trust
-
Form EFFECT SAFE & GREEN HOLDINGS
-
Form EFFECT CREDIT SUISSE AG
-
Form DEFA14A BlackRock Science & Tech
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B3 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form EFFECT Zeo Energy Corp.
-
Form 497K Innovator ETFs Trust